search
Back to results

Optimizing Individual Nutrition in Preterm Very Low Birth Weight Infants

Primary Purpose

Infant, Premature, Diseases, Infant, Small for Gestational Age

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Individualized Nutrition
Optimized nutrition
Sponsored by
University of Texas Southwestern Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Infant, Premature, Diseases

Eligibility Criteria

undefined - 7 Days (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Preterm infants <29 weeks GA and SGA infants <35 weeks GA born at Parkland Health and Hospital System
  • Maternal plan to breastfeed or to use milk from the donor milk bank
  • From birth to 1 week of life

Exclusion Criteria:

  • Patients on comfort care only
  • Patients with major congenital abnormalities
  • Patients who are too unstable for the first 7 days to have an accurate length measurement

Sites / Locations

  • UT Southwestern Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Individualized and Optimized Nutrition

Optimized Nutrition

Arm Description

Individualized nutrition Optimized nutrition

Optimized nutrition

Outcomes

Primary Outcome Measures

Growth Velocity
Rate of weight gain [g x kg-1 x day-1] and length velocity [cm x week-1]
Linear Growth Velocity
Increase in body length per week from birth to 36 weeks postmenstrual age or discharge

Secondary Outcome Measures

Disproportionate Growth (Increased Fat Mass): BMI >90th Centile
Disproportionate growth (increased fat mass): BMI > 90th centile for sex and age
Blood Pressure
Systolic blood pressure (calm or sleeping)
Hypertension
Systolic blood pressure beyond limit defined by the SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN
Neurodevelopment
Bayley Scale of Infant and Toddler Development, Third Edition (BSID-III): cognitive composite score Higher scores mean a better outcome. The composite scaled score has a mean of 100 and a SD of 15, a floor of 55 and a ceiling of 145. Bayley, N. (2006). Bayley Scales of Infant and Toddler Development- Third Edition. San Antonio, TX: Harcourt Assessment. DOI: 10.1177/0734282906297199
Neurodevelopment
Bayley Scale of Infant and Toddler Development, Third Edition (BSID-III): language composite score Higher scores mean a better outcome. The composite scaled score has a mean of 100 and a SD of 15, a floor of 47 and a ceiling of 153. Bayley, N. (2006). Bayley Scales of Infant and Toddler Development- Third Edition. San Antonio, TX: Harcourt Assessment. DOI: 10.1177/0734282906297199
Assessment of Biomarkers of Adiposity
Serum levels of adipokines: leptin, adiponectin and resistin
Assessment of Renal Glomerular Function
Assessment of renal glomerular function: Serum level of cystatin C
Comparison of Weight With Expected Value for Age and Gender
Comparison of weight with expected value for age and gender: Z score for weight
Comparison of Length With Expected Value for Age and Gender
Comparison of length with expected value for age and gender: Z score for length
Comparison of Head Size With Expected Value for Age and Gender
Comparison of head size with expected value for age and gender: Z score for fronto-occipital circumference
Comparison of Rate of Weight Gain With Expected Value for Age and Gender
Comparison of rate of weight gain with expected value for age and gender: change in z score for weight from birth to time frame
Comparison of Rate of Linear Growth With Expected Value for Age and Gender
Comparison of rate of linear growth with expected value for age and gender: Change in z score for length from birth to time frame
Comparison of Rate of Head Growth With Expected Value for Age and Gender
Change in z score for fronto-occipital circumference from birth to time frame
Body Composition
Percent fat mass measured by Dexascan

Full Information

First Posted
February 12, 2015
Last Updated
March 29, 2023
Sponsor
University of Texas Southwestern Medical Center
Collaborators
Children's Medical Center Dallas, The Gerber Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT02372136
Brief Title
Optimizing Individual Nutrition in Preterm Very Low Birth Weight Infants
Official Title
Individualizing and Optimizing Nutrition to Prevent Metabolic Syndrome and To Improve Neurodevelopment in Preterm and Small for Gestational Age Infants
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
January 2016 (undefined)
Primary Completion Date
February 4, 2020 (Actual)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Texas Southwestern Medical Center
Collaborators
Children's Medical Center Dallas, The Gerber Foundation

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
In preterm infants fed human milk, milk needs to be fortified to meet nutrient recommendations. Fortification can be 1) standard, 2) individualized (adjusted based on daily human milk nutrient analysis and milk volume), or 3) optimized (adjusted based on growth rate and serum analyses). The first specific aim will determine whether individualized and optimized nutrition during hospitalization results in improved growth in the neonatal intensive care unit (NICU) in extremely low gestational age (GA) neonates (ELGANs, <29 weeks) and in small for GA (SGA, birth weight <10th percentile for GA) preterm infants compared with optimized nutrition. The second specific aim will determine whether individualized and optimized nutrition in the NICU improves neurodevelopmental outcomes (acquisition of development milestones) and reduces the risk of disproportionate growth (i.e., excess fat) in the NICU and findings suggestive of metabolic syndrome in the first 3 years of life.
Detailed Description
Hypotheses: Primary hypothesis: In preterm infants (GA <29 weeks or GA <35 weeks and SGA) individualized and optimized nutrition will increase velocity of growth (weight gain velocity by 2 g x kg-1 x day-1 and length velocity by 0.2 cm per week) from birth to 36 weeks of postmenstrual age (GA plus postnatal age) or discharge (whichever comes first) in comparison with optimized nutrition. Secondary hypotheses: Individualized and optimized nutrition will improve neurodevelopmental outcome and reduce the risk of disproportionate growth (excess fat) in the NICU and findings suggestive of metabolic syndrome in the first 3 years of life. Study design: Double-blinded randomized controlled trial (RCT): After consent, 150 neonates will be randomized to one of two groups. Study intervention: Patients will be randomized to either: Control: optimized nutrition: Milk fortification will be based on current recommendations and optimized by adjustment of nutrients once a week based on blood levels of urea nitrogen and albumin and velocity of growth (weight and length). Intervention: Individualized and optimized nutrition: Milk fortification will be optimized as in control neonates. In addition, nutrition will be individualized every day. Milk fortification will be adjusted based on daily measurements of macronutrients in human milk using near-infrared analysis. Randomization will be done by computer provided by a statistician using random block allocation and stratification by GA and size for age (AGA [appropriate for GA] 23-28 weeks, SGA 23-28 weeks and SGA 29-34 weeks). Twins and multiples will be randomized to the same arm of the study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infant, Premature, Diseases, Infant, Small for Gestational Age

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
Only the statistician and the formula technicians know the patients' allocation.
Allocation
Randomized
Enrollment
120 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Individualized and Optimized Nutrition
Arm Type
Experimental
Arm Description
Individualized nutrition Optimized nutrition
Arm Title
Optimized Nutrition
Arm Type
Other
Arm Description
Optimized nutrition
Intervention Type
Dietary Supplement
Intervention Name(s)
Individualized Nutrition
Other Intervention Name(s)
Targeted, customized
Intervention Description
Intake of macronutrients (protein, fat, and carbohydrate) will be individualized every day by adding one or more macronutrients to human milk based on daily measurements using near-infrared analysis. In patients receiving less milk than 140 ml x kg-1 x day-1 fortification of human milk will be adjusted to reach at least the average concentrations of protein, fat, and carbohydrate in donor's milk (Wojcik. J Am Diet Assoc. 2009 Jan;109:137-40) and 20 cal/oz as provided by the Mother's Milk Bank of North Texas. In those receiving at least 140 ml x kg-1 x day-1 of milk at 24 cal/oz fortification will be adjusted to meet recent guidelines from the the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition (ESPGHAN) (Agostoni et al. J Pediatr Gastroenterol Nutr. 2010 Jan;50:85-91).
Intervention Type
Dietary Supplement
Intervention Name(s)
Optimized nutrition
Other Intervention Name(s)
Adjustable
Intervention Description
Milk fortification will be based on current recommendations and optimized by adjustment of nutrients once a week based on blood levels of urea nitrogen (corrected for serum creatinine level) and albumin and velocity of growth (weight and length).
Primary Outcome Measure Information:
Title
Growth Velocity
Description
Rate of weight gain [g x kg-1 x day-1] and length velocity [cm x week-1]
Time Frame
36 (range 35-37) weeks postmenstrual age or discharge (whichever comes first)
Title
Linear Growth Velocity
Description
Increase in body length per week from birth to 36 weeks postmenstrual age or discharge
Time Frame
36 (range 35-37) weeks postmenstrual age or discharge (whichever comes first)
Secondary Outcome Measure Information:
Title
Disproportionate Growth (Increased Fat Mass): BMI >90th Centile
Description
Disproportionate growth (increased fat mass): BMI > 90th centile for sex and age
Time Frame
36 (range 35-37) weeks postmenstrual age or discharge (whichever comes first)
Title
Blood Pressure
Description
Systolic blood pressure (calm or sleeping)
Time Frame
36 (range 35-37) weeks postmenstrual age or discharge (whichever comes first)
Title
Hypertension
Description
Systolic blood pressure beyond limit defined by the SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN
Time Frame
at 1-3 years of age
Title
Neurodevelopment
Description
Bayley Scale of Infant and Toddler Development, Third Edition (BSID-III): cognitive composite score Higher scores mean a better outcome. The composite scaled score has a mean of 100 and a SD of 15, a floor of 55 and a ceiling of 145. Bayley, N. (2006). Bayley Scales of Infant and Toddler Development- Third Edition. San Antonio, TX: Harcourt Assessment. DOI: 10.1177/0734282906297199
Time Frame
18-41 months adjusted age (postnatal age corrected for prematurity)
Title
Neurodevelopment
Description
Bayley Scale of Infant and Toddler Development, Third Edition (BSID-III): language composite score Higher scores mean a better outcome. The composite scaled score has a mean of 100 and a SD of 15, a floor of 47 and a ceiling of 153. Bayley, N. (2006). Bayley Scales of Infant and Toddler Development- Third Edition. San Antonio, TX: Harcourt Assessment. DOI: 10.1177/0734282906297199
Time Frame
18-41 months adjusted age (postnatal age corrected for prematurity) 18-41 months adjusted age (postnatal age corrected for prematurity) 18-41 months corrected age 18-41 months
Title
Assessment of Biomarkers of Adiposity
Description
Serum levels of adipokines: leptin, adiponectin and resistin
Time Frame
at 1-3 years of age
Title
Assessment of Renal Glomerular Function
Description
Assessment of renal glomerular function: Serum level of cystatin C
Time Frame
at 1-3 years of age
Title
Comparison of Weight With Expected Value for Age and Gender
Description
Comparison of weight with expected value for age and gender: Z score for weight
Time Frame
36 (range 35-37) weeks postmenstrual age or discharge (whichever comes first)
Title
Comparison of Length With Expected Value for Age and Gender
Description
Comparison of length with expected value for age and gender: Z score for length
Time Frame
36 (range 35-37) weeks postmenstrual age or discharge (whichever comes first)
Title
Comparison of Head Size With Expected Value for Age and Gender
Description
Comparison of head size with expected value for age and gender: Z score for fronto-occipital circumference
Time Frame
36 (range 35-37) weeks postmenstrual age or discharge (whichever comes first)
Title
Comparison of Rate of Weight Gain With Expected Value for Age and Gender
Description
Comparison of rate of weight gain with expected value for age and gender: change in z score for weight from birth to time frame
Time Frame
36 (range 35-37) weeks postmenstrual age or discharge (whichever comes first)
Title
Comparison of Rate of Linear Growth With Expected Value for Age and Gender
Description
Comparison of rate of linear growth with expected value for age and gender: Change in z score for length from birth to time frame
Time Frame
36 (range 35-37) weeks postmenstrual age or discharge (whichever comes first)
Title
Comparison of Rate of Head Growth With Expected Value for Age and Gender
Description
Change in z score for fronto-occipital circumference from birth to time frame
Time Frame
36 (range 35-37) weeks postmenstrual age or discharge (whichever comes first)
Title
Body Composition
Description
Percent fat mass measured by Dexascan
Time Frame
at 1 year of age and 3 years of age
Other Pre-specified Outcome Measures:
Title
Mortality
Description
Percent of infants who died from birth to discharge from the neonatal intensive care unit
Time Frame
Until discharge from the neonatal intensive care unit
Title
Necrotizing Enterocolitis
Description
Percentage of infants who developed necrotizing enterocolitis stage II or greater (using the modified Bell stage classification) in the neonatal intensive care unit
Time Frame
Until discharge from the neonatal intensive care unit

10. Eligibility

Sex
All
Maximum Age & Unit of Time
7 Days
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Preterm infants <29 weeks GA and SGA infants <35 weeks GA born at Parkland Health and Hospital System Maternal plan to breastfeed or to use milk from the donor milk bank From birth to 1 week of life Exclusion Criteria: Patients on comfort care only Patients with major congenital abnormalities Patients who are too unstable for the first 7 days to have an accurate length measurement
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Luc P Brion, MD
Organizational Affiliation
UT Southwestern Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
UT Southwestern Medical Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75390-9063
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The datasets generated and/or analyzed during the current study will be available from the corresponding author on reasonable request after completion and publication of all follow-up data.
IPD Sharing Time Frame
after completion and publication of all follow-up data
IPD Sharing Access Criteria
on reasonable request
Citations:
PubMed Identifier
32071367
Citation
Brion LP, Rosenfeld CR, Heyne R, Brown LS, Lair CS, Petrosyan E, Jacob T, Caraig M, Burchfield PJ. Optimizing individual nutrition in preterm very low birth weight infants: double-blinded randomized controlled trial. J Perinatol. 2020 Apr;40(4):655-665. doi: 10.1038/s41372-020-0609-1. Epub 2020 Feb 18.
Results Reference
background
Links:
URL
https://DOI.org/10.1038/s41372-020-0609-1
Description
DOI

Learn more about this trial

Optimizing Individual Nutrition in Preterm Very Low Birth Weight Infants

We'll reach out to this number within 24 hrs